Biomarker discovery through artificial intelligence and personalized medicine

Biomarker discovery through artificial intelligence and personalized medicine Priya Hays, CEO and Science Writer at Hays Documentation Specialists, LLC, discusses biomarker discovery through artificial intelligence and personalized medicine. Biomarkers can be broadly defined as objectively measured indicators of normal, pathogenic, or pharmacologic biological responses, or of a therapeutic strategy. Artificial intelligence (AI) can be thought of as enabling computers to replicate human behavior in making decisions and solving complex tasks without human behavior or interference. The nexus of where biomarker discovery meets AI is in personalized or precision medicine.